证券代码：301126 证券简称：达嘉维康 公告编号：2026-005 湖南达嘉维康医药产业股份有限公司 关于对外担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、担保情况概述 湖南达嘉维康医药产业股份有限公司（以下简称"公司"）为满足公司全资子 公司及控股子公司日常生产经营和业务发展资金需要，保证公司业务顺利开展，公 司于 2025 年 4 月 17 日、2025 年 5 月 12 日分别召开的第四届董事会第十四次会议及 2024 年年度股东会审议通过《关于 2025 年度担保额度预计的议案》，同意公司 2025 年度为公司全资子公司及控股子公司提供担保，担保额度预计不超过 30 亿元。具体内容 详见公司于 2025 年 4 月 21 日在巨潮资讯网（http://www.cninfo.com.cn）上披露的《关于 2025 年度担保额度预计的公告》（公告编号：2025-026）。 二、对外担保进展情况 近日，公司与广发银行股份有限公司长沙分行（以下简称"广发银行"）签订 了《最高额保证合同》，同意为全资子公司湖南达嘉维康医药有限公司（以下 ...

证券代码：301126 证券简称：达嘉维康 公告编号：2026-004 湖南达嘉维康医药产业股份有限公司 关于对外担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、担保情况概述 湖南达嘉维康医药产业股份有限公司（以下简称"公司"）为满足公司全资子 公司及控股子公司日常生产经营和业务发展资金需要，保证公司业务顺利开展，公 司于 2025 年 4 月 17 日、2025 年 5 月 12 日分别召开的第四届董事会第十四次会议及 2024 年年度股东会审议通过《关于 2025 年度担保额度预计的议案》，同意公司 2025 年度为公司全资子公司及控股子公司提供担保，担保额度预计不超过 30 亿元。具体内容 详见公司于 2025 年 4 月 21 日在巨潮资讯网（http://www.cninfo.com.cn）上披露的《关于 2025 年度担保额度预计的公告》（公告编号：2025-026）。 二、对外担保进展情况 近日，公司与中国光大银行股份有限公司长沙新华支行（以下简称"光大银行"） 签订了《最高额保证合同》，同意为全资子公司达嘉维康生物制药有限公 ...

证券代码：301126 证券简称：达嘉维康 公告编号：2026-003 湖南达嘉维康医药产业股份有限公司 关于对外担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 湖南达嘉维康医药产业股份有限公司（以下简称"公司"）为满足公司全资 子公司及控股子公司日常生产经营和业务发展资金需要，保证公司业务顺利开展， 公司于 2025 年 4 月 17 日、2025 年 5 月 12 日分别召开的第四届董事会第十四次会 议及 2024 年年度股东大会审议通过《关于 2025 年度担保额度预计的议案》，同意 公司 2025 年度为公司全资子公司及控股子公司提供担保，担保额度预计不超过 30 亿 元。具体内容详见公司于 2025 年 4 月 21 日在巨潮资讯网（http://www.cninfo.com.cn） 上披露的《关于 2025 年度担保额度预计的公告》（公告编号：2025-026）。 二、对外担保进展情况 近日，公司与中国银行股份有限公司长沙市开福支行（以下简称"中国银行"） 签订了《最高额保证合同》，同意为控股子公司湖南天济草堂制药 ...

Group 1 - The Hunan Province held a conference to promote the development of the private economy, awarding 100 outstanding private entrepreneurs for their contributions to regional economic growth and the construction of a modern industrial system [1][2] - Notable recipients include leaders from over 20 listed companies, showcasing the vitality and potential of the private economy in Hunan [1] - Key figures from companies such as SANY Heavy Industry, Lens Technology, Aier Eye Hospital, and others were recognized, representing various advantageous industrial sectors including engineering machinery, consumer manufacturing, biomedicine, and new energy technology [1][2] Group 2 - Executives from several listed companies' subsidiaries also received awards, highlighting the collaborative development within Hunan's industrial chain [2] - Entrepreneurs at critical stages of the IPO process were also honored, indicating the effective cultivation of Hunan's private economic tier [2] - The awarded entrepreneurs span key industries such as engineering machinery, green agricultural products, biomedicine, and advanced materials, playing a crucial role in transforming traditional industries and fostering new emerging sectors [2]

Core Viewpoint - The company, Dajia Weikang (301126), is expected to report a loss in 2025 due to intensified industry competition and goodwill impairment, while its major shareholder plans to reduce its stake by up to 3% [1][2][3]. Group 1: Financial Performance - The company forecasts its 2025 revenue to be between 5.5 billion to 6 billion yuan, representing a year-on-year growth of 5.09% to 14.65% [2]. - The anticipated net loss for 2025 is projected to be between 250 million to 300 million yuan, primarily due to increased industry competition and goodwill impairment [2]. Group 2: Shareholder Actions - The controlling shareholder's concerted action party, Changsha Tongjia Investment Management Partnership, plans to reduce its holdings by no more than 6.16 million shares, which accounts for 3% of the total share capital, between March 10 and June 9, 2026 [3]. Group 3: Product Development Progress - The company is collaborating with Hunan University and other institutions to establish a clinical research center in the field of regenerative medicine, aiming to promote technology transfer [4]. - Ongoing product developments include the sodium salt of sacubitril/valsartan, which is in the technical review stage, and the application for ezetimibe/atorvastatin calcium tablets is being prepared, which may impact future business layout [4].

Core Viewpoint - The company Dajia Weikang (301126.SZ) announced a share reduction plan by its controlling shareholder's action partner, Changsha Tongjia Investment Management Partnership, which holds 4.77% of the company's total shares [1] Group 1: Share Reduction Announcement - Changsha Tongjia plans to reduce its holdings by up to 6,162,096 shares, representing 3.00% of the total share capital, within three months starting from March 10, 2026 [1] - As of the announcement date, Changsha Tongjia holds 9,800,000 shares of Dajia Weikang [1] Group 2: Financial Performance Forecast - Dajia Weikang expects to achieve an operating income of between 550 million to 600 million yuan for the year 2025, compared to 523.34 million yuan in the previous year [2] - The company anticipates a net loss attributable to shareholders of between 25 million to 30 million yuan for 2025, a significant decline from a profit of 2.66 million yuan in the previous year [2] - The expected net profit after deducting non-recurring gains and losses is also projected to be between -25 million to -30 million yuan, down from 2.56 million yuan in the previous year [2] Group 3: Initial Public Offering Details - Dajia Weikang was listed on the Shenzhen Stock Exchange's ChiNext board on December 7, 2021, with an initial public offering of 51.63 million shares at a price of 12.37 yuan per share [2] - The total funds raised amounted to 639 million yuan, with a net amount of 569 million yuan after deducting issuance costs, exceeding the original plan by 59.42 million yuan [2] - The funds are intended for chain pharmacy expansion, smart logistics center projects, and repayment of bank loans [2]

Core Viewpoint - Several shareholders across various companies are planning to reduce their stakes, indicating potential shifts in ownership and investor sentiment in the market [1] Shareholder Reductions - Xuelang Environment's shareholders Yang Jianping and Xu Huifen plan to reduce their holdings by no more than 3% [1] - Dajia Weikang's actual controller's concerted actors also intend to reduce their stakes by no more than 3% [1] - Zhongfutong's shareholders, including Changde Zhongke, Zhejiang Zhongke, and Jinjiang Ronglei, plan to collectively reduce their holdings by no more than 0.68% [1] - Huitong Technology's directors Zhong Ming and Yang Jian plan to reduce their stakes by no more than 1.64% [1] - Shuangjie Electric's director Xu Zhuan intends to reduce his holdings by no more than 378.9 thousand shares [1] - Hu Silicon Industry's shareholder investment fund plans to reduce its holdings by no more than 99.15 million shares [1] - Zhongji United's director and senior vice president Ma Dongsheng plans to reduce his holdings by no more than approximately 110 thousand shares [1] - Lushan New Materials' shareholders Lushan Information and Wang Jiasheng plan to collectively reduce their stakes by no more than 3% [1] - Zhidi Technology's Zhikong Investment plans to reduce its holdings by no more than 24.18 thousand shares [1] - Yinxin Technology's directors and senior management plan to collectively reduce their holdings by no more than 242.7 thousand shares [1] - Huizhi Micro's shareholder Great Fund Phase II plans to reduce its holdings by 0.57542% [1] - Jingda Shares' shareholder Li Guangrong and concerted actors have already collectively reduced their holdings by 64.3 million shares [1] - Huashu High-tech's shareholder Xingwang Construction has reduced its holdings by 236.81 thousand shares [1] Regulatory Actions - Tiansheng New Materials is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure [1] - Yahui Long is also under investigation by the CSRC for suspected violations of information disclosure [1]

Summary of Key Points Core Viewpoint - On February 6, 14 A-share listed companies disclosed plans for share reductions, with no companies announcing share increases on the same day [1][3]. Group 1: Companies Disclosing Share Reductions - Tianan New Materials: Shareholders Liang Kaihong and Tianyao Group plan to reduce their holdings [2][4]. - Zhongfutong: Shareholders plan to reduce a total of up to 0.68% of shares [2][4]. - Zhidi Technology: Shareholder Zhikong Investment intends to reduce up to 0.30% of shares [2][4]. - Yinhui Technology: Directors and executives plan to reduce a total of up to 0.51% of shares [2][4]. - Dalian Electric Porcelain: Vice General Manager Miao Shi and executives plan to reduce their holdings [2][4]. - Xuelang Environment: Shareholders Yang Jianping and Xu Huifen plan to reduce a total of up to 3% of shares [2][4]. - Perfect World: Actual controller Chi Yufeng reduced 32.9793 million shares [2][4]. - Huitong Technology: Directors Zhong Ming and Yang Jian plan to reduce a total of up to 1.64% of shares [2][4]. - Shuangjie Electric: Director Xu Zhuan plans to reduce up to 0.47% of shares [2][4]. - Dajia Weikang: One of the actual controllers plans to reduce up to 3% of shares [2][4]. - Hu Silicon Industry: The second largest shareholder, the National Big Fund, plans to reduce up to 3% of shares [2][4]. - Lushan New Materials: Controlling shareholders and concerted actors plan to reduce a total of up to 3% of shares [2][4]. - Zhongji United: Directors and executives, including Wang Xijun, plan to reduce a total of up to 0.91% of shares [2][4]. - Sanfu Shares: Shareholder Yuanheng Technology plans to reduce a total of up to 3% of shares [2][4].

Group 1 - The controlling shareholder and actual controller's concerted action partner, Changsha Tongjia Investment Management Partnership (Limited Partnership), plans to reduce its holdings in Dajia Weikang (301126.SZ) by up to 6.162 million shares, accounting for 3.00% of the company's total share capital [1] - The reduction will take place within three months from March 10, 2026, to June 9, 2026, through centralized bidding and block trading methods [1] - The announcement marks a significant move by the major shareholder, indicating potential changes in the company's ownership structure [1]

Company Announcements - Tongde Chemical's assets in Beijing have been frozen due to a financing lease contract dispute with Zhejiang Zhiyin Financial Leasing Co., Ltd. The company is in communication to resolve the issue while maintaining normal operations [3] - Jindi Co. plans to acquire 100% equity of Guangzhou Yuni Precision Co., Ltd. for 116 million yuan, focusing on precision stamping products for automotive applications [4] - XWANDA's subsidiary reached a settlement in a lawsuit involving 2.314 billion yuan, with an expected impact on the company's net profit of 500 million to 800 million yuan for 2025 [5] - Wantong Expressway intends to invest approximately 5.42 billion yuan in the renovation and expansion of the Lianhuo Expressway, with construction expected to start in 2026 [6] - ZTE Corporation plans to invest 200 million yuan in the Guangdong-Hong Kong-Macao Greater Bay Area Venture Capital Fund, which focuses on technology and manufacturing sectors [7] - Fawer Automotive Components has completed the relocation of its Chongqing factory, which will enhance production capacity to 4 million shock absorbers annually [8] - YHLO has been investigated by the China Securities Regulatory Commission for suspected information disclosure violations, but its operations remain normal [9] - Crystal Integrated plans to invest 2 billion yuan to acquire 100% equity of Anhui Jingyi Integrated Circuit Co., Ltd., focusing on advanced semiconductor manufacturing [10] - Dongtian Micro plans to invest 400 million yuan in a global R&D center and manufacturing headquarters in Dongguan [11] Performance Reports - New Hope reported a January sales revenue of 1.628 billion yuan from 1.1218 million pigs, a year-on-year decline of 10.03% [13] - Tianbang Foods achieved a January sales revenue of 674 million yuan from 682,000 pigs, with a year-on-year increase of 9.93% [14] - Guoji General reported a net profit of 58.5157 million yuan for 2025, a year-on-year increase of 45.71% [15] - Zhongtong Bus sold 1,231 vehicles in January, marking a year-on-year growth of 35.72% [16] - Kunming Pharmaceutical Group reported a net profit of 350 million yuan for 2025, a year-on-year decline of 46% [17] - Focus Technology achieved a net profit of 504 million yuan for 2025, a year-on-year increase of 11.73% [18] - China Shipbuilding Special Gas reported a net profit of 347 million yuan for 2025, a year-on-year increase of 12.92% [20] Shareholding Changes - Lushan New Materials' controlling shareholder plans to reduce its stake by up to 3% [22] - Zhongji United's two directors plan to reduce their holdings by up to 0.91% [23] - Dajia Weikang's controlling shareholder plans to reduce its stake by up to 3% [24] - Hu Silicon Industry's National Integrated Circuit Industry Investment Fund plans to reduce its stake by up to 3% [25] Major Contracts - Chuangyuan Technology's subsidiary is a recommended candidate for a National Grid project with a pre-bid amount of 94.7672 million yuan [27]